Brixadi (buprenorphine) Subcutaneous Injection, 64 mg Monthly Prefilled Syringe, 0.18 mL, Each
Brixadi is a long-acting buprenorphine formulation for the treatment of moderate to severe opioid use disorder. This monthly prefilled syringe delivers 64 mg of buprenorphine in a 0.18 mL subcutaneous injection, providing sustained medication levels over the dosing interval. It is intended for use in patients who have initiated treatment with a transmucosal buprenorphine product.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Brixadi is a long-acting buprenorphine formulation for the treatment of moderate to severe opioid use disorder. This monthly prefilled syringe delivers 64 mg of buprenorphine in a 0.18 mL subcutaneous injection, providing sustained medication levels over the dosing interval. It is intended for use in patients who have initiated treatment with a transmucosal buprenorphine product.
1 vendor
